fda approval for tirzepatide Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide gains FDA approval for

Clinical studies show patients may lose a significant percentage of body weight, often ranging from 15% to over 20% over time

Healing cascade activation may begin quickly, but measurable structural repair in intestinal lining models takes longer

Ratiometric fluorescence imaging of cellular glutathione

This article looks at the relationship between salidroside and the HPA axis, examining how this compound may support healthy cortisol regulation and improve the bodys ability to adapt to stress

Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man